Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Arcadia Bio (RKDA)

Arcadia Bio (RKDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,618
  • Shares Outstanding, K 6,267
  • Annual Sales, $ 1,460 K
  • Annual Income, $ -13,480 K
  • 60-Month Beta -2.01
  • Price/Sales 23.76
  • Price/Cash Flow N/A
  • Price/Book 4.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.75
  • Number of Estimates 1
  • High Estimate -0.75
  • Low Estimate -0.75
  • Prior Year -0.46
  • Growth Rate Est. (year over year) -63.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.82 +280.77%
on 08/05/19
9.15 -24.26%
on 08/15/19
+4.04 (+139.79%)
since 07/22/19
3-Month
1.82 +280.77%
on 08/05/19
9.15 -24.26%
on 08/15/19
+2.08 (+42.89%)
since 05/22/19
52-Week
1.82 +280.77%
on 08/05/19
10.40 -33.37%
on 02/28/19
+0.70 (+11.24%)
since 08/22/18

Most Recent Stories

More News
Arcadia Biosciences: 2Q Earnings Snapshot

DAVIS, Calif. (AP) _ Arcadia Biosciences Inc. (RKDA) on Wednesday reported second-quarter net income of $4.2 million, after reporting a loss in the same period a year earlier.

RKDA : 6.98 (+0.29%)
Arcadia Biosciences Announces Second-Quarter and First-Half 2019 Financial Results and Business Highlights

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation to improve the quality and nutritional content of crops, today released its financial and...

RKDA : 6.98 (+0.29%)
Thinking about buying stock in Aurora Cannabis, Arcadia Biosciences, Roku, Tilray, or Yangtze River Port and Logistics?

InvestorsObserver issues critical PriceWatch Alerts for ACB, RKDA, ROKU, TLRY, and YRIV.

RKDA : 6.98 (+0.29%)
ACB.TO : 7.73 (-1.02%)
Thinking about buying stock in Aurora Cannabis, Activision Blizzard, Arcadia Biosciences, Tilray, or Uber Technologies?

InvestorsObserver issues critical PriceWatch Alerts for ACB, ATVI, RKDA, TLRY, and UBER.

RKDA : 6.98 (+0.29%)
ACB.TO : 7.73 (-1.02%)
ATVI : 49.07 (+0.06%)
UBER : 33.99 (-2.64%)
Verdeca Receives USDA Approval of HB4(R) Drought Tolerant Soybeans

Bioceres Crop Solutions Corp. (NYSE American: BIOX), announced today that Verdeca, a joint venture between BCS Holding Inc., a wholly owned subsidiary of Bioceres Crop Solutions Corp. (the "Company") and...

RKDA : 6.98 (+0.29%)
Vapen MJ Ventures to Construct and Operate Hawaiian Hemp Extraction Facility

Vapen MJ Ventures (OTCQX:VAPNF; CSE: VAPN) ("Vapen MJ") a fully integrated agricultural technology, services and property management company in the regulated cannabis industry, today announced a new partnership...

RKDA : 6.98 (+0.29%)
Arcadia Biosciences Announces Joint Venture with Legacy Ventures Hawaii To Grow, Extract and Sell Superior Hemp Products

-- Venture joins Arcadia's extensive genetic expertise and resources with Legacy's proven experience in extraction and distribution.

RKDA : 6.98 (+0.29%)
/C O R R E C T I O N -- Arcadia Biosciences, Inc./

In the news release, Arcadia Biosciences Announces Date of Second-Quarter 2019 Financial Results and Business Highlights Conference Call, issued 05-Aug-2019 by Arcadia Biosciences, Inc. over PR Newswire,...

RKDA : 6.98 (+0.29%)
Arcadia Biosciences Announces Date of Second-Quarter 2019 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced its plan to release its second-quarter...

RKDA : 6.98 (+0.29%)
Arcadia Biosciences (RKDA) Reports Q1 Loss, Misses Revenue Estimates

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -103.28% and -60.50%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

RKDA : 6.98 (+0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade RKDA with:

Business Summary

Arcadia Biosciences, Inc. is engaged in developing and commercializing agricultural products primarily in the United States. The Company's product includes nitrogen use crops, salt tolerant plants, sunflower oil and shelf-life produce. Arcadia Biosciences, Inc. is headquartered in Davis, California.

See More

Key Turning Points

2nd Resistance Point 8.23
1st Resistance Point 7.59
Last Price 6.95
1st Support Level 5.95
2nd Support Level 4.95

See More

52-Week High 10.40
Fibonacci 61.8% 7.12
Last Price 6.95
Fibonacci 50% 6.11
Fibonacci 38.2% 5.10
52-Week Low 1.82

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar